{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:31:42Z","timestamp":1792474302916,"version":"4.5.0"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Progressive multifocal leukoencephalopathy (PML) is a rare, often fatal demyelinating disease of the central nervous system caused by reactivation of latent JC virus in immunocompromised individuals. Despite advances in understanding its pathogenesis, PML remains a diagnostic challenge due to its diverse clinical manifestations, radiographic overlap with other disorders, low incidence and subsequent lack of clinical familiarity. Diagnostic delays, often extending months after symptom onset, are common and contribute to poor outcomes. This review outlines the key clinical features, risk factors, diagnostic and neuroradiographic findings of PML to aid practicing neurologists in timely recognition and expedited diagnosis. We review emerging biomarkers and advanced diagnostic tools to identify PML. We also compare PML with its common mimics to underscore diagnostic pitfalls and how to overcome them. Novel and experimental therapies are beyond the scope of this article; instead, we focus on equipping neurologists with a framework grounded in patient data and clinical experience to establish timely diagnoses of PML.<\/jats:p>","DOI":"10.3389\/fneur.2026.1692522","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:14:01Z","timestamp":1774930441000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Progressive multifocal leukoencephalopathy \u2014 a diagnostic guide for the clinical neurologist"],"prefix":"10.3389","volume":"17","author":[{"given":"Dan Tong","family":"Jia","sequence":"first","affiliation":[{"name":"Department of Neurology, Northwestern University","place":["Chicago, IL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1086\/597126","article-title":"Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors","volume":"199","author":"Egli","year":"2009","journal-title":"J Infect Dis"},{"key":"ref2","first-page":"59","article-title":"Progressive multifocal leukoencephalopathy in patients with HIV infection","volume":"4","author":"Berger","year":"1998","journal-title":"J Neuro-Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1056\/NEJMoa051847","article-title":"Progressive multifocal leukoencephalopathy in a patient treated with natalizumab","volume":"353","author":"Langer-Gould","year":"2005","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1053\/j.ajkd.2025.02.606","article-title":"Progressive multifocal leukoencephalopathy in kidney transplant recipients: a retrospective multicenter nationwide case series","volume":"86","author":"Sanson","year":"2025","journal-title":"Am J Kidney Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/brain\/81.1.93","article-title":"Progressive multifocal leuko-encephalopathy: a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease","volume":"81","author":"Astrom","year":"1958","journal-title":"Brain"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1212\/NXI.0000000000000618","article-title":"Progressive multifocal leukoencephalopathy: a 25-year retrospective cohort study","volume":"6","author":"Anand","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41582-020-00427-y","article-title":"Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease","volume":"17","author":"Cortese","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1136\/jnnp.2009.179002","article-title":"Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy","volume":"81","author":"Lima","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1212\/wnl.0b013e31821a446b","article-title":"Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"76","author":"Vermersch","year":"2011","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1212\/WNL.0000000000003740","article-title":"No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML","volume":"88","author":"Landi","year":"2017","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/acn3.301","article-title":"Diagnostic delay in progressive multifocal leukoencephalopathy","volume":"3","author":"Miskin","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"632535","DOI":"10.3389\/fneur.2021.632535","article-title":"Clinical presentation and disease course of 37 consecutive cases of progressive multifocal leukoencephalopathy (PML) at a German tertiary-care hospital: a retrospective observational study","volume":"12","author":"Graf","year":"2021","journal-title":"Front Neurol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1086\/595299","article-title":"Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a Nationwide cohort study","volume":"199","author":"Engsig","year":"2009","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1212\/01.wnl.0000194227.16696.11","article-title":"Seizures and their outcome in progressive multifocal leukoencephalopathy","volume":"66","author":"Lima","year":"2006","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s13365-015-0414-3","article-title":"Predictors and characteristics of seizures in survivors of progressive multifocal leukoencephalopathy","volume":"22","author":"Miskin","year":"2016","journal-title":"J Neuro-Oncol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1080\/13550280701469178","article-title":"Spinal cord lesions of progressive multifocal leukoencephalopathy in an acquired immunodeficiency syndrome patient","volume":"13","author":"Bernal-Cano","year":"2007","journal-title":"J Neuro-Oncol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1440-1789.2008.00981.x","article-title":"Progressive multifocal leukoencephalopathy showing extensive spinal cord involvement in a patient with lymphocytopenia","volume":"29","author":"Takeda","year":"2009","journal-title":"Neuropathology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/ana.20431","article-title":"JC virus granule cell neuronopathy: a novel clinical syndrome distinct from progressive multifocal leukoencephalopathy","volume":"57","author":"Koralnik","year":"2005","journal-title":"Ann Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00415-014-7530-5","article-title":"Heterogeneous imaging characteristics of JC virus granule cell neuronopathy (GCN): a case series and review of the literature","volume":"262","author":"Wijburg","year":"2015","journal-title":"J Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e498","DOI":"10.1212\/WNL.0000000000004926","article-title":"The national incidence of PML in Sweden, 1988\u20132013","volume":"90","author":"Iacobaeus","year":"2018","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/brain\/awac237","article-title":"Progressive multifocal leukoencephalopathy: epidemiology and spectrum of predisposing conditions","volume":"146","author":"Joly","year":"2023","journal-title":"Brain"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1212\/wnl.0000000000003739","article-title":"Natalizumab-associated PML","volume":"88","author":"Schwab","year":"2017","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1177\/1352458514567728","article-title":"Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy","volume":"21","author":"Vennegoor","year":"2015","journal-title":"Mult Scler"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1001\/jamaneurol.2019.2670","article-title":"Progressive multifocal leukoencephalopathy incidence and risk stratification among Natalizumab users in France","volume":"77","author":"Vukusic","year":"2020","journal-title":"JAMA Neurol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3389\/fimmu.2017.00577","article-title":"Immune reconstitution inflammatory syndrome unmasking or worsening AIDS-related progressive multifocal leukoencephalopathy: a literature review","volume":"8","author":"Fournier","year":"2017","journal-title":"Front Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1073\/pnas.87.9.3479","article-title":"Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells","volume":"87","author":"Tada","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1056\/NEJMoa051586","article-title":"Progressive multifocal leukoencephalopathy after Natalizumab therapy for Crohn's disease","volume":"353","author":"Van Assche","year":"2005","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1056\/NEJMoa051782","article-title":"Progressive multifocal leukoencephalopathy complicating treatment with Natalizumab and interferon Beta-1a for multiple sclerosis","volume":"353","author":"Kleinschmidt-DeMasters","year":"2005","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":"Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases","volume":"9","author":"Clifford","year":"2010","journal-title":"Lancet Neurol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/nejmoa1107829","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"366","author":"Bloomgren","year":"2012","journal-title":"N Engl J Med"},{"key":"ref31","article-title":"New algorithm to estimate risk of natalizumab-associated progressive multifocal leukoencephalopathy (PML) in antiJCV antibody positive patients: analyses of clinical trial data to provide further temporal precision and inform clinical practice","author":"Koendgen","year":"2016","journal-title":"Mult Scler J"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1474-4422(17)30282-X","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies","volume":"16","author":"Ho","year":"2017","journal-title":"Lancet Neurol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/acn3.51130","article-title":"Improving risk-stratification of natalizumab-associated PML","volume":"8","author":"Tugemann","year":"2021","journal-title":"Annals Clin Translational Neurol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1212\/01.wnl.0000341766.59028.9d","article-title":"Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function","volume":"72","author":"Khatri","year":"2009","journal-title":"Neurology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1212\/WNL.0b013e31822e55e7","article-title":"Immune reconstitution inflammatory syndrome in natalizumab-associated PML","volume":"77","author":"Tan","year":"2011","journal-title":"Neurology"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ana.25070","article-title":"To do or not to do? Plasma exchange and timing of steroid administration in progressive multifocal leukoencephalopathy","volume":"82","author":"Scarpazza","year":"2017","journal-title":"Ann Neurol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1212\/WNL.0b013e3182478d4b","article-title":"Fatal PML associated with efalizumab therapy: insights into integrin \u03b1L\u03b22 in JC virus control","volume":"78","author":"Schwab","year":"2012","journal-title":"Neurology"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e1815","DOI":"10.1212\/WNL.0000000000005529","article-title":"Progressive multifocal leukoencephalopathy after fingolimod treatment","volume":"90","author":"Berger","year":"2018","journal-title":"Neurology"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1517\/14740338.2015.1093620","article-title":"Risk of progressive multifocal leukoencephalopathy in patients with multiple sclerosis","volume":"14","author":"Faulkner","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1212\/wnl.0000000000202034","article-title":"Progressive multifocal leukoencephalopathy (PML) with anti-CD20 and other monoclonal antibody (mAb) therapies in multiple sclerosis (P8-3.016)","volume":"100","author":"Sharma","year":"2023","journal-title":"Neurology"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1007\/s00415-016-8217-x","article-title":"Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases","volume":"263","author":"Maas","year":"2016","journal-title":"J Neurol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/transplantology2010004","article-title":"JC polyomavirus and transplantation: implications for virus reactivation after immunosuppression in transplant patients and the occurrence of PML disease","volume":"2","author":"Hildreth","year":"2021","journal-title":"Transplantology"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/ana.22408","article-title":"Progressive multifocal leukoencephalopathy in transplant recipients","volume":"70","author":"Mateen","year":"2011","journal-title":"Ann Neurol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/ccr3.2612","article-title":"Progressive multifocal leukoencephalopathy (PML) following autologous peripheral blood stem cell transplantation for multiple myeloma","volume":"8","author":"Bennett","year":"2020","journal-title":"Clin Case Reports"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1016\/j.bbmt.2015.11.505","article-title":"Progressive multifocal leukoencephalopathy associated with hematopoietic stem cell transplant (HSCT) has better prognosis than PML associated with monoclonal antibodies or chemotherapy in hematological malignancies: analysis of a case series","volume":"22","author":"Raajasekar","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.jiac.2024.02.025","article-title":"Development of progressive multifocal leukoencephalopathy after cord blood transplantation in a patient with refractory angioimmunoblastic T-cell lymphoma","volume":"30","author":"Aiba","year":"2024","journal-title":"J Infect Chemother"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1111\/bjh.16349","article-title":"Postallogeneic transplantation progressive multifocal leukoencephalopathy successfully treated by nivolumab","volume":"188","author":"Uzunov","year":"2020","journal-title":"Br J Haematol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1182\/bloodadvances.2017008201","article-title":"Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review","volume":"1","author":"Neil","year":"2017","journal-title":"Blood Adv"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","article-title":"Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the research on adverse drug events and reports project","volume":"113","author":"Carson","year":"2009","journal-title":"Blood"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1002\/cncr.28712","article-title":"Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the southern network on adverse reactions (SONAR) project","volume":"120","author":"Carson","year":"2014","journal-title":"Cancer"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz024","article-title":"The incidence and predisposing factors of John Cunningham virus-induced progressive multifocal leukoencephalopathy in southern Finland: a population-based study","volume":"6","author":"Kartau","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1002\/art.22657","article-title":"Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease","volume":"56","author":"Calabrese","year":"2007","journal-title":"Arthritis Rheum"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.autrev.2008.07.006","article-title":"Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?","volume":"8","author":"Molloy","year":"2008","journal-title":"Autoimmun Rev"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"e000388","DOI":"10.1136\/lupus-2020-000388","article-title":"Prevalence of progressive multifocal leukoencephalopathy (PML) in adults and children with systemic lupus erythematosus","volume":"7","author":"Kapoor","year":"2020","journal-title":"Lupus Sci Med"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1513\/AnnalsATS.201610-750OC","article-title":"Sarcoidosis increases risk of hospitalized infection. A population-based study, 1976-2013","volume":"14","author":"Ungprasert","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"e9088","DOI":"10.1371\/journal.pone.0009088","article-title":"Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations","volume":"5","author":"Sweiss","year":"2010","journal-title":"PLoS One"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1001\/jamaneurol.2023.0841","article-title":"Characteristics of progressive multifocal leukoencephalopathy associated with sarcoidosis without therapeutic immune suppression","volume":"80","author":"McEntire","year":"2023","journal-title":"JAMA Neurol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1212\/wnl.0000000000000318","article-title":"Progressive multifocal leukoencephalopathy in patients with sarcoidosis","volume":"82","author":"Jamilloux","year":"2014","journal-title":"Neurology"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"578248","DOI":"10.1016\/j.jneuroim.2023.578248","article-title":"Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia treated with pembrolizumab","volume":"385","author":"Varmpompiti","year":"2023","journal-title":"J Neuroimmunol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","article-title":"PML diagnostic criteria: consensus statement from the AAN neuroinfectious disease section","volume":"80","author":"Berger","year":"2013","journal-title":"Neurology"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/1352458508096870","article-title":"Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA","volume":"15","author":"Iacobaeus","year":"2009","journal-title":"Mult Scler"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.2169\/internalmedicine.56.7689","article-title":"Brain biopsy is more reliable than the DNA test for JC virus in cerebrospinal fluid for the diagnosis of progressive multifocal leukoencephalopathy","volume":"56","author":"Ikeda","year":"2017","journal-title":"Intern Med"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12987-020-00227-y","article-title":"Cerebrospinal fluid analysis in 108 patients with progressive multifocal leukoencephalopathy","volume":"17","author":"M\u00f6hn","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/jcm.33.2.484-486.1995","article-title":"Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy","volume":"33","author":"Fong","year":"1995","journal-title":"J Clin Microbiol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.3390\/v16121950","article-title":"Performance of ultrasensitive polymerase chain reaction testing for JC polyomavirus in cerebrospinal fluid compared with pathological diagnosis of progressive multifocal leukoencephalopathy","volume":"16","author":"Takahashi","year":"2024","journal-title":"Viruses"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1212\/WNL.0b013e31823b9b27","article-title":"Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS","volume":"77","author":"Kuhle","year":"2011","journal-title":"Neurology"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamaneurol.2018.0094","article-title":"Association of Progressive Multifocal Leukoencephalopathy Lesion Volume with JC virus polymerase chain reaction results in cerebrospinal fluid of Natalizumab-treated patients with multiple sclerosis","volume":"75","author":"Wijburg","year":"2018","journal-title":"JAMA Neurol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1007\/s11604-025-01837-y","article-title":"Overview of MRI findings in progressive multifocal leukoencephalopathy","volume":"43","author":"Mori","year":"2025","journal-title":"Jpn J Radiol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/ana.24153","article-title":"Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"76","author":"Warnke","year":"2014","journal-title":"Ann Neurol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1073274817729901","DOI":"10.1177\/1073274817729901","article-title":"Progressive multifocal leukoencephalopathy and monoclonal antibodies: a review","volume":"24","author":"Bohra","year":"2017","journal-title":"Cancer Control"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/WNL.52.2.253","article-title":"JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy","volume":"52","author":"Koralnik","year":"1999","journal-title":"Neurology"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bjid.2019.01.005","article-title":"Polyomaviruses BK and JC DNA infection in peripheral blood cells from blood donors","volume":"23","author":"Haghighi","year":"2019","journal-title":"Braz J Infect Dis"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/brain\/awab419","article-title":"The neuroradiology of progressive multifocal leukoencephalopathy: a clinical trial perspective","volume":"145","author":"Baldassari","year":"2022","journal-title":"Brain"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/ana.23676","article-title":"Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy","volume":"72","author":"Yousry","year":"2012","journal-title":"Ann Neurol"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3174\/ajnr.A2024","article-title":"Use of diffusion-weighted imaging to evaluate the initial response of progressive multifocal leukoencephalopathy to highly active antiretroviral therapy: early experience","volume":"31","author":"Buckle","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s004150170099","article-title":"Lesion extension detected by diffusion-weighted magnetic resonance imaging in progressive multifocal leukoencephalopathy","volume":"248","author":"Ohta","year":"2001","journal-title":"J Neurol"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.4103\/aian.aian_650_22","article-title":"Milky way sign in progressive multifocal leukoencephalopathy","volume":"25","author":"Agarwal","year":"2022","journal-title":"Ann Indian Acad Neurol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/qjmed\/hcaf156","article-title":"Milky way sign in PML","volume":"118","author":"Gupta","year":"2025","journal-title":"QJM: Int J Med"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"110490","DOI":"10.1016\/j.clinimag.2025.110490","article-title":"I saw the \u201cmilky way sign\u201d and the \u201cbarbell sign\u201d in the same patient","volume":"123","author":"Gon\u00e7alves","year":"2025","journal-title":"Clin Imaging"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3174\/ajnr.A7145","article-title":"MRI shrimp sign in cerebellar progressive multifocal leukoencephalopathy: description and validation of a novel observation","volume":"42","author":"Adra","year":"2021","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"293","DOI":"10.4103\/0028-3886.79149","article-title":"\"hot cross bun\" sign in HIV-related progressive multifocal leukoencephalopathy","volume":"59","author":"Yadav","year":"2011","journal-title":"Neurol India"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jns.2017.02.021","article-title":"The \u2018across the pons\u2019 sign: a possible novel radiographic finding in natalizumab-associated progressive multifocal leukoencephalopathy","volume":"375","author":"Budhram","year":"2017","journal-title":"J Neurol Sci"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1212\/WNL.0000000000207155","article-title":"Teaching NeuroImage: cerebellar atrophy due to JC virus granule cell Neuronopathy: a clinical syndrome distinct from classic PML","volume":"101","author":"Silva-Rosas","year":"2023","journal-title":"Neurology"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/RCT.0000000000000719","article-title":"\u201cBarbell sign\u201d: a diagnostic imaging finding in progressive multifocal leukoencephalopathy","volume":"42","author":"Bezuidenhout","year":"2018","journal-title":"J Comput Assist Tomogr"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1136\/jnnp-2015-311411","article-title":"MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS","volume":"87","author":"Wattjes","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/197140091302600203","article-title":"Progressive multifocal leukoencephalopathy presenting as IRIS in an AIDS patient. A case report and literature review","volume":"26","author":"Corti","year":"2013","journal-title":"Neuroradiol J"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"349","DOI":"10.17305\/bjbms.2017.2092","article-title":"A prominent lactate peak as a potential key magnetic resonance spectroscopy (MRS) feature of progressive multifocal leukoencephalopathy (PML): Spectrum pattern observed in three patients","volume":"17","author":"Kozi\u0107","year":"2017","journal-title":"Bosn J Basic Med Sci"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.2169\/internalmedicine.56.8080","article-title":"PET imaging of (18)F-FDG, (11)C-methionine, (11)C-flumazenil, and (11)C-4DST in progressive multifocal leukoencephalopathy","volume":"56","author":"Ishibashi","year":"2017","journal-title":"Intern Med"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"e42030","DOI":"10.7759\/cureus.42030","article-title":"Misdiagnosed progressive multifocal leukoencephalopathy (PML) in an HIV-negative patient with discoid lupus: a case report","volume":"15","author":"Mousa","year":"2023","journal-title":"Cureus"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"P1.2-049","DOI":"10.1212\/wnl.92.15","article-title":"Progressive multifocal leukoencephalopathy mimicking acute ischemic stroke in a patient with idiopathic CD4 Lymphocytopenia (P1.2-049)","volume":"92","author":"Kolikonda","year":"2019","journal-title":"Neurology"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S1474-4422(12)70205-3","article-title":"HIV infection and stroke: current perspectives and future directions","volume":"11","author":"Benjamin","year":"2012","journal-title":"Lancet Neurol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1634\/theoncologist.2014-0060","article-title":"Seizure prognosis in brain tumors: new insights and evidence-based management","volume":"19","author":"Vecht","year":"2014","journal-title":"Oncologist"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.2967\/jnumed.113.131516","article-title":"Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET\/MR Imaging","volume":"56","author":"Fink","year":"2015","journal-title":"J Nucl Med"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1212\/WNL.0000000000006213","article-title":"The utility of FDG-PET imaging in distinguishing PML-IRIS from PML in a patient treated with natalizumab","volume":"91","author":"Baheerathan","year":"2018","journal-title":"Neurology"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jocn.2011.08.043","article-title":"Progressive multifocal leukoencephalopathy (PML) mimicking high-grade glioma on delayed F-18 FDG PET imaging","volume":"19","author":"Mertens","year":"2012","journal-title":"J Clin Neurosci"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"2324709620939802","DOI":"10.1177\/2324709620939802","article-title":"Atypical multiple sclerosis lesions or progressive multifocal leukoencephalopathy lesions: that is the question","volume":"8","author":"De Mercanti","year":"2020","journal-title":"J Investig Med High Impact Case Rep"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"e245271","DOI":"10.1136\/bcr-2021-245271","article-title":"Cerebellar progressive multifocal leukoencephalopathy associated with pulmonary sarcoidosis","volume":"14","author":"Patel","year":"2021","journal-title":"BMJ Case Rep"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"577871","DOI":"10.1016\/j.jneuroim.2022.577871","article-title":"Clinical features and diagnosis of neurosarcoidosis - review article","volume":"368","author":"Barreras","year":"2022","journal-title":"J Neuroimmunol"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"643216","DOI":"10.1155\/2015\/643216","article-title":"JC virus PCR detection is not infallible: a fulminant case of progressive multifocal leukoencephalopathy with false-negative cerebrospinal fluid studies despite progressive clinical course and radiological findings","volume":"2015","author":"Babi","year":"2015","journal-title":"Case Rep Neurol Med"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12883-019-1476-2","article-title":"Improving detection of JC virus by ultrafiltration of cerebrospinal fluid before polymerase chain reaction for the diagnosis of progressive multifocal leukoencephalopathy","volume":"19","author":"Nakamichi","year":"2019","journal-title":"BMC Neurol"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00415-025-13452-y","article-title":"JC virus PCR assay reporting for PML: promises, perils, and pitfalls","volume":"272","author":"Avasarala","year":"2025","journal-title":"J Neurol"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1056\/NEJMoa1803396","article-title":"Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis","volume":"380","author":"Wilson","year":"2019","journal-title":"N Engl J Med"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"16961","DOI":"10.1038\/s41598-024-68034-1","article-title":"Clinical application and evaluation of metagenomic next-generation sequencing in pathogen detection for suspected central nervous system infections","volume":"14","author":"Yuan","year":"2024","journal-title":"Sci Rep"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf390","article-title":"Metagenomic next-generation sequencing of cerebrospinal fluid: first year experience at a tertiary referral hospital","author":"Alvarez Mulett","year":"2025","journal-title":"Clin Infect Dis"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/ana.25437","article-title":"Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients","volume":"85","author":"Dalla Costa","year":"2019","journal-title":"Ann Neurol"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"e1003","DOI":"10.1212\/NXI.0000000000001003","article-title":"Serum neurofilament levels and PML risk in patients with multiple sclerosis treated with natalizumab","volume":"8","author":"Fissolo","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"e1003014","DOI":"10.1371\/journal.ppat.1003014","article-title":"Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy","volume":"8","author":"Perkins","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fimmu.2018.00138","article-title":"Understanding progressive multifocal leukoencephalopathy risk in multiple sclerosis patients treated with immunomodulatory therapies: a bird's eye view","volume":"9","author":"Mills","year":"2018","journal-title":"Front Immunol"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3390\/pathogens14100989","article-title":"Mechanisms of Interleukin-10-mediated immunosuppression in viral infections","volume":"14","author":"Guo","year":"2025","journal-title":"Pathogens"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"1584083","DOI":"10.3389\/fneur.2025.1584083","article-title":"JCV-specific cell-based assays for PML risk assessment in lupus and multiple sclerosis patients with and without natalizumab","volume":"16","author":"Wu","year":"2025","journal-title":"Front Neurol"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1007\/s00330-020-07362-y","article-title":"Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML","volume":"31","author":"Alleg","year":"2021","journal-title":"Eur Radiol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1692522\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:14:05Z","timestamp":1774930445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1692522\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":111,"alternative-id":["10.3389\/fneur.2026.1692522"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1692522","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"article-number":"1692522"}}